We are Boehringer Ingelheim, UK - a different kind of pharmaceutical company
Family-owned. Purpose-led. Innovation-driven: We serve mankind by improving health for people and animals.
Boehringer Ingelheim was first established in Germany in 1885 and is now one of the top 20 pharmaceutical companies in the world. To this day we remain family-owned, meaning we have the freedom to pursue our purpose - identifying health challenges of the future, and targeting areas of unmet need.
In human pharma, we do this through scientific innovation – taking on the biggest challenges in medicine. We invest in sustainable healthcare - planning for the long term alongside the NHS and our partners in the veterinary world. And we are driving digital transformation by investing in technology to accelerate healthcare improvements.
In animal health, we stand for advanced prevention. Our animal health business is now the second largest in the world, with more than 200 products for dogs, cats, horses, pigs, cattle and poultry.
Our UK head office is in Bracknell and we employ around 750 people throughout the UK.
Find out more about our company in the UK
-
Our Company UK
As a company, we consider it our duty to take the best possible care of the protection and health of our employees, our patients and society. Boehringer Ingelheim is engaged at various levels of action to contain and cope with the global spread of COVID-19.
-
Our Company UK
-
-
-
Ethics & Compliance
Find out about our commitment to legal and regulatory ethics and compliance
-
Ethics & Compliance
Our commitment to transparency
-
Human Health
Funding opportunities including those related to clinical research
-
Terms and Conditions
NP-GB-101387 | November 2020